{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:49:59Z","timestamp":1791485399248,"version":"4.3.4"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bbr.2019.111967","type":"journal-article","created":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T10:36:00Z","timestamp":1558780560000},"page":"111967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Obsessive-compulsive disorder and growth factors: A comparative review"],"prefix":"10.1016","volume":"372","author":[{"given":"Sara","family":"Savaheli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolhassan","family":"Ahmadiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2019.111967_bib0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fpsyt.2013.00021","article-title":"Perceived stress in obsessive\u2013compulsive disorder is related with obsessive but not compulsive symptoms","volume":"4","author":"Morgado","year":"2013","journal-title":"Front. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbr.2019.111967_bib0010","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/mp.2017.154","article-title":"Revealing the complex genetic architecture of obsessive\u2013compulsive disorder using meta-analysis","volume":"23","author":"Genetics","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbr.2019.111967_bib0015","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.cpr.2011.06.007","article-title":"Early versus late onset obsessive\u2013compulsive disorder: evidence for distinct subtypes","volume":"31","author":"Taylor","year":"2011","journal-title":"Clin. Psychol. Rev."},{"issue":"1","key":"10.1016\/j.bbr.2019.111967_bib0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mp.2008.94","article-title":"The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication","volume":"15","author":"Ruscio","year":"2010","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbr.2019.111967_bib0025","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.pharmthera.2011.09.006","article-title":"Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment","volume":"132","author":"Pittenger","year":"2011","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bbr.2019.111967_bib0030","article-title":"Selective serotonin re\u2010uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)","author":"Soomro","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.bbr.2019.111967_bib0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.euroneuro.2007.08.004","article-title":"Relationship between antidepressants and IGF-1 system in the brain: possible role in cognition","volume":"18","author":"Grunbaum-Novak","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2019.111967_bib0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.npp.1301571","article-title":"Interaction between BDNF and serotonin: role in mood disorders","volume":"33","author":"Martinowich","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"29","key":"10.1016\/j.bbr.2019.111967_bib0045","doi-asserted-by":"crossref","first-page":"10827","DOI":"10.1073\/pnas.0402141101","article-title":"Essential role of brain-derived neurotrophic factor in adult hippocampal function","volume":"101","author":"Monteggia","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.bbr.2019.111967_bib0050","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/mp.2016.232","article-title":"OCD-like behavior is caused by dysfunction of thalamo-amygdala circuits and upregulated TrkB\/ERK-MAPK signaling as a result of SPRED2 deficiency","volume":"23","author":"Ullrich","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbr.2019.111967_bib0055","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrendo.2013.77","article-title":"Diagnosis and treatment of growth hormone deficiency in adults","volume":"9","author":"Kargi","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbr.2019.111967_bib0060","doi-asserted-by":"crossref","DOI":"10.1038\/nrendo.2018.22","article-title":"Growth hormone\u2014past, present and future","author":"Ranke","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbr.2019.111967_bib0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ygcen.2014.03.041","article-title":"Extrapituitary growth hormone and growth?","volume":"205","author":"Harvey","year":"2014","journal-title":"Gen. Comp. Endocrinol."},{"issue":"11","key":"10.1016\/j.bbr.2019.111967_bib0070","doi-asserted-by":"crossref","first-page":"e960","DOI":"10.1038\/tp.2016.203","article-title":"Growth hormone biases amygdala network activation after fear learning","volume":"6","author":"Gisabella","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"9","key":"10.1016\/j.bbr.2019.111967_bib0075","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.psyneuen.2006.07.002","article-title":"Altered nocturnal growth hormone (GH) secretion in obsessive compulsive disorder","volume":"31","author":"Kluge","year":"2006","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.bbr.2019.111967_bib0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000054530","article-title":"Influence of different serotonin receptor subtypes on growth hormone secretion","volume":"71","author":"Valverde","year":"2000","journal-title":"Neuroendocrinology"},{"issue":"10","key":"10.1016\/j.bbr.2019.111967_bib0085","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0006-3223(96)00549-5","article-title":"Dopamine function in obsessive\u2014compulsive disorder: growth hormone response to apomorphine stimulation","volume":"42","author":"Brambilla","year":"1997","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbr.2019.111967_bib0090","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-1781(96)03032-6","article-title":"Noradrenergic receptor sensitivity in obsessive-compulsive disorders: I. Growth hormone response to clonidine stimulation","volume":"69","author":"Brambilla","year":"1997","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.bbr.2019.111967_bib0095","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1176\/ajp.150.6.961","article-title":"Elevated growth hormone responses to pyridostigmine in obsessive-compulsive disorder: evidence of cholinergic supersensitivity","volume":"150","author":"Lucey","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbr.2019.111967_bib0100","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fnins.2013.00220","article-title":"A cholinergic hypothesis of the unconscious in affective disorders","volume":"7","author":"Vakalopoulos","year":"2013","journal-title":"Front. Neurosci."},{"issue":"01","key":"10.1016\/j.bbr.2019.111967_bib0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-1014269","article-title":"The growth hormone response to baclofen in obsessive compulsive disorder: does the GABA-B receptor mediate obsessive anxiety?","volume":"27","author":"Lucey","year":"1994","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"10.1016\/j.bbr.2019.111967_bib0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0165-1781(98)00124-3","article-title":"Growth hormone response to growth hormone-releasing hormone stimulation in obsessive\u2013compulsive disorder","volume":"81","author":"Brambilla","year":"1998","journal-title":"Psychiatry Res."},{"issue":"5","key":"10.1016\/j.bbr.2019.111967_bib0115","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.smrv.2004.03.005","article-title":"GHRH and sleep","volume":"8","author":"Obal","year":"2004","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.bbr.2019.111967_bib0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ghir.2004.03.006","article-title":"Reciprocal interactions between the GH axis and sleep","volume":"14","author":"Van Cauter","year":"2004","journal-title":"Growth Horm. Igf Res."},{"issue":"6","key":"10.1016\/j.bbr.2019.111967_bib0125","doi-asserted-by":"crossref","first-page":"E963","DOI":"10.1152\/ajpendo.00527.2003","article-title":"Sleep enhances nocturnal plasma ghrelin levels in healthy subjects","volume":"286","author":"Dzaja","year":"2004","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"issue":"4","key":"10.1016\/j.bbr.2019.111967_bib0130","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.psyneuen.2008.10.016","article-title":"Nocturnal levels of ghrelin and leptin and sleep in chronic insomnia","volume":"34","author":"Motivala","year":"2009","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.bbr.2019.111967_bib0135","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41398-018-0196-5","article-title":"Circulating insulin-like growth factor I modulates mood and is a biomarker of vulnerability to stress: from mouse to man","volume":"8","author":"Santi","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbr.2019.111967_bib0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fncel.2017.00014","article-title":"Insulin-like growth factor 1: at the crossroads of brain development and aging","volume":"11","author":"Wrigley","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"7","key":"10.1016\/j.bbr.2019.111967_bib0145","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1210\/er.2004-0024","article-title":"The insulin-like growth factor system and its pleiotropic functions in brain","volume":"26","author":"Russo","year":"2005","journal-title":"Endocr. Rev."},{"issue":"11","key":"10.1016\/j.bbr.2019.111967_bib0150","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.3390\/ijms18112441","article-title":"Neurotrophic and neuroregenerative effects of GH\/IGF1","volume":"18","author":"Bianchi","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbr.2019.111967_bib0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1100\/tsw.2006.22","article-title":"Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain","volume":"6","author":"\u00c5berg","year":"2006","journal-title":"The Scientific World Journal"},{"issue":"1","key":"10.1016\/j.bbr.2019.111967_bib0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00018-012-1020-7","article-title":"Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes","volume":"70","author":"Duric","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.bbr.2019.111967_bib0165","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.parkreldis.2013.11.005","article-title":"Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson\u2019s disease, multiple system atrophy and progressive supranuclear palsy","volume":"20","author":"Numao","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbr.2019.111967_bib0170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pnpbp.2013.01.008","article-title":"Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients","volume":"44","author":"Palomino","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbr.2019.111967_bib0175","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jad.2013.07.041","article-title":"High insulin-like growth factor-1 in patients with bipolar I disorder: a trait marker?","volume":"151","author":"Kim","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"1-2","key":"10.1016\/j.bbr.2019.111967_bib0180","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.psychres.2014.03.042","article-title":"Elevated serum levels of FGF-2, NGF and IGF-1 in patients with manic episode of bipolar disorder","volume":"218","author":"Liu","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbr.2019.111967_bib0185","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.brainres.2007.01.147","article-title":"Decreased expression of insulin-like growth factor binding protein 2 in the prefrontal cortex of subjects with bipolar disorder and its regulation by lithium treatment","volume":"1147","author":"Bezchlibnyk","year":"2007","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.bbr.2019.111967_bib0190","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/JCP.0b013e3182189d86","article-title":"Treatment with antidepressants increases insulin-like growth factor-I in cerebrospinal fluid","volume":"31","author":"Schilling","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2019.111967_bib0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000446918","article-title":"Serum levels of insulin-like growth Factor-1 and obsessive-compulsive disorder: a case-control study","volume":"74","author":"Rosso","year":"2016","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.bbr.2019.111967_bib0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ajp.2017.03.013","article-title":"Plasma insulin-like growth factor-1 levels and response to selective serotonin reuptake inhibitor treatment: a prospective study of medication-na\u00efve OCD patients","volume":"28","author":"Narayanaswamy","year":"2017","journal-title":"Asian J. Psychiatr."},{"issue":"3","key":"10.1016\/j.bbr.2019.111967_bib0205","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nn.3321","article-title":"Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids","volume":"16","author":"Labou\u00e8be","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.bbr.2019.111967_bib0210","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.molmet.2016.06.011","article-title":"Insulin in the nervous system and the mind: functions in metabolism, memory, and mood","volume":"5","author":"Lee","year":"2016","journal-title":"Mol. Metab."},{"issue":"10","key":"10.1016\/j.bbr.2019.111967_bib0215","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/1381612033455323","article-title":"Insulin and the blood-brain barrier","volume":"9","author":"Woods","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbr.2019.111967_bib0220","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mce.2015.08.013","article-title":"Metabolic, anabolic, and mitogenic insulin responses: a tissue-specific perspective for insulin receptor activators","volume":"415","author":"Bedinger","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.bbr.2019.111967_bib0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1749-8104-5-7","article-title":"Insulin receptor signaling in the development of neuronal structure and function","volume":"5","author":"Chiu","year":"2010","journal-title":"Neural Dev."},{"issue":"11","key":"10.1016\/j.bbr.2019.111967_bib0230","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrn4019","article-title":"Hippocampal insulin resistance and cognitive dysfunction","volume":"16","author":"Biessels","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"11","key":"10.1016\/j.bbr.2019.111967_bib0235","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/hipo.20470","article-title":"Diet\u2010induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle\u2010aged rats","volume":"18","author":"Stranahan","year":"2008","journal-title":"Hippocampus"},{"issue":"5","key":"10.1016\/j.bbr.2019.111967_bib0240","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.neuron.2008.06.001","article-title":"Seeing the light: insulin receptors and the CNS","volume":"58","author":"Needleman","year":"2008","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.bbr.2019.111967_bib0245","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/jnc.13909","article-title":"The neuronal insulin receptor in its environment","volume":"140","author":"Gralle","year":"2017","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.bbr.2019.111967_bib0250","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1503\/jpn.140327","article-title":"An integrated molecular landscape implicates the regulation of dendritic spine formation through insulin-related signalling in obsessive\u2013compulsive disorder","volume":"41","author":"van de Vondervoort","year":"2016","journal-title":"Journal of psychiatry & neuroscience: JPN"},{"key":"10.1016\/j.bbr.2019.111967_bib0255","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1073\/pnas.1500877112","article-title":"Insulin resistance in brain alters dopamine turnover and causes behavioral disorders","volume":"112","author":"Kleinridders","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.bbr.2019.111967_bib0260","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0006-3223(03)00569-9","article-title":"Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment","volume":"54","author":"Musselman","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2019.111967_bib0265","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11920-011-0245-8","article-title":"A review of the association between depression and insulin resistance: pitfalls of secondary analyses or a promising new approach to prevention of type 2 diabetes?","volume":"14","author":"Silva","year":"2012","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.bbr.2019.111967_bib0270","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fendo.2011.00054","article-title":"Insulin signaling and autism","volume":"2","author":"Stern","year":"2011","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"10.1016\/j.bbr.2019.111967_bib0275","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1530-0277.2007.00589.x","article-title":"Insulin but not insulin growth factor\u20101 correlates with craving in currently drinking alcohol\u2010dependent patients","volume":"32","author":"Leggio","year":"2008","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"4","key":"10.1016\/j.bbr.2019.111967_bib0280","first-page":"171","article-title":"A psychometric evaluation of adult patients with type 1 (insulin-dependent) diabetes mellitus: prevalence of psychological dysfunction and relationship to demographic variables, metabolic control and complications","volume":"14","author":"Winocour","year":"1990","journal-title":"Diabetes Res."},{"issue":"1","key":"10.1016\/j.bbr.2019.111967_bib0285","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/13651501.2012.697563","article-title":"The association of the metabolic profile in diabetes mellitus type 2 patients with obsessive-compulsive symptomatology and depressive symptomatology: new insights","volume":"17","author":"Kontoangelos","year":"2013","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"2","key":"10.1016\/j.bbr.2019.111967_bib0290","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.genhosppsych.2012.10.004","article-title":"Metabolic syndrome and obsessive\u2013compulsive disorder: a naturalistic Italian study","volume":"35","author":"Albert","year":"2013","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"23","key":"10.1016\/j.bbr.2019.111967_bib0295","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1101\/gad.841400","article-title":"Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system","volume":"14","author":"Bibel","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbr.2019.111967_bib0300","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fnmol.2014.00039","article-title":"Regulation of neurotrophin receptor (Trk) signaling: suppressor of cytokine signaling 2 (SOCS2) is a new player","volume":"7","author":"Uren","year":"2014","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.bbr.2019.111967_bib0305","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4103\/1673-5374.156967","article-title":"The p75 neurotrophin receptor: at the crossroad of neural repair and death","volume":"10","author":"Meeker","year":"2015","journal-title":"Neural Regen. Res."},{"issue":"2","key":"10.1016\/j.bbr.2019.111967_bib0310","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pr.111.005108","article-title":"Brain-derived neurotrophic factor and neuropsychiatric disorders","volume":"64","author":"Autry","year":"2012","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.bbr.2019.111967_bib0315","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","article-title":"Neurotrophins: roles in neuronal development and function","volume":"24","author":"Huang","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"issue":"5762","key":"10.1016\/j.bbr.2019.111967_bib0320","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1120972","article-title":"Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress","volume":"311","author":"Berton","year":"2006","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.bbr.2019.111967_bib0325","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrn1726","article-title":"The yin and yang of neurotrophin action","volume":"6","author":"Lu","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.bbr.2019.111967_bib0330","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tem.2013.10.006","article-title":"BDNF mediates adaptive brain and body responses to energetic challenges","volume":"25","author":"Marosi","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"issue":"1-2","key":"10.1016\/j.bbr.2019.111967_bib0335","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jad.2009.07.009","article-title":"Serum levels of brain-derived neurotrophic factor in drug-naive obsessive\u2013compulsive patients: a case\u2013control study","volume":"122","author":"Maina","year":"2010","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.bbr.2019.111967_bib0340","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1017\/S1092852912000363","article-title":"Symptom dimensional approach and BDNF in unmedicated obsessive-compulsive patients: an exploratory study","volume":"16","author":"Dos Santos","year":"2011","journal-title":"CNS Spectr."},{"issue":"3","key":"10.1016\/j.bbr.2019.111967_bib0345","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.psychres.2012.03.034","article-title":"Neurotrophic factors in obsessive-compulsive disorder","volume":"199","author":"Fontenelle","year":"2012","journal-title":"Psychiatry Res."},{"issue":"1\u20132","key":"10.1016\/j.bbr.2019.111967_bib0350","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jad.2011.04.002","article-title":"Brain-derived neurotrophic factor (BDNF) plasma levels in drug-na\u00efve OCD patients are lower than those in healthy people, but are not lower than those in drug-treated OCD patients","volume":"133","author":"Wang","year":"2011","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.bbr.2019.111967_bib0355","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","article-title":"The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function","volume":"112","author":"Egan","year":"2003","journal-title":"Cell"},{"issue":"18","key":"10.1016\/j.bbr.2019.111967_bib0360","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1523\/JNEUROSCI.0348-04.2004","article-title":"Variant brain-derived neurotrophic factor (BDNF)(Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons","volume":"24","author":"Chen","year":"2004","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.bbr.2019.111967_bib0365","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1601-183X.2008.00418.x","article-title":"Genetic susceptibility to obsessive-compulsive hoarding: the contribution of neurotrophic tyrosine kinase receptor type 3 gene 1","volume":"7","author":"Alonso","year":"2008","journal-title":"Genes Brain Behav."},{"issue":"6","key":"10.1016\/j.bbr.2019.111967_bib0370","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.biopsych.2007.06.020","article-title":"Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder","volume":"63","author":"Alonso","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbr.2019.111967_bib0375","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/377003","article-title":"Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder","volume":"73","author":"Hall","year":"2003","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.bbr.2019.111967_bib0380","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/15622970701245003","article-title":"Investigating the role of the brain-derived neurotrophic factor (BDNF) val66met variant in obsessive-compulsive disorder (OCD)","volume":"9","author":"Hemmings","year":"2008","journal-title":"World J. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.bbr.2019.111967_bib0385","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/ajmg.b.30930","article-title":"The role of the brain\u2010derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive\u2010compulsive disorder (OCD)","volume":"150","author":"Katerberg","year":"2009","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"issue":"6","key":"10.1016\/j.bbr.2019.111967_bib0390","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/mds.20849","article-title":"Brain\u2010derived neurotrophic factor: a genetic risk factor for obsessive\u2013compulsive disorder and Tourette syndrome?","volume":"21","author":"Klaffke","year":"2006","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.bbr.2019.111967_bib0395","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3109\/15622975.2015.1012226","article-title":"Do obsessive\u2013compulsive disorder and Tourette syndrome share a common susceptibility gene? An association study of the BDNF Val66Met polymorphism in the Chinese Han population","volume":"16","author":"Liu","year":"2015","journal-title":"World J. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2019.111967_bib0400","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1017\/S146114570400495X","article-title":"Brain-derived neurotrophic factor V66M polymorphism in childhood-onset obsessive\u2013compulsive disorder","volume":"8","author":"M\u00f6ssner","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"12","key":"10.1016\/j.bbr.2019.111967_bib0405","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1038\/sj.npp.1301394","article-title":"A large case\u2013control study of common functional SLC6A4 and BDNF variants in obsessive\u2013compulsive disorder","volume":"32","author":"Wendland","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.bbr.2019.111967_bib0410","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00041444-200512000-00002","article-title":"No association between brain-derived neurotrophic factor gene and obsessive-compulsive disorder","volume":"15","author":"Zai","year":"2005","journal-title":"Psychiatr. Genet."},{"issue":"11","key":"10.1016\/j.bbr.2019.111967_bib0415","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.euroneuro.2013.08.001","article-title":"Association study between BDNF gene variants and Mexican patients with obsessive\u2013compulsive disorder","volume":"23","author":"M\u00e1rquez","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2019.111967_bib0420","first-page":"65","article-title":"BDNF gene and obsessive compulsive disorder risk,symptom dimensions and treatment response","volume":"38","author":"MJ","year":"2017","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.bbr.2019.111967_bib0425","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jad.2015.07.023","article-title":"BDNF Val66Met polymorphism and plasma levels in Chinese Han population with obsessive-compulsive disorder and generalized anxiety disorder","volume":"186","author":"Wang","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.bbr.2019.111967_bib0430","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.janxdis.2013.02.012","article-title":"The interaction between Comt and Bdnf variants influences obsessive\u2013compulsive-related dysfunctional beliefs","volume":"27","author":"Alonso","year":"2013","journal-title":"J. Anxiety Disord."},{"issue":"12","key":"10.1016\/j.bbr.2019.111967_bib0435","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.jpsychires.2013.08.012","article-title":"BDNF Val66Met modifies the risk of childhood trauma on obsessive-compulsive disorder","volume":"47","author":"Hemmings","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbr.2019.111967_bib0440","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fnhum.2015.00130","article-title":"A pilot study on the effect of cognitive training on BDNF serum levels in individuals with Parkinson\u2019s disease","volume":"9","author":"Angelucci","year":"2015","journal-title":"Front. Hum. Neurosci."},{"issue":"8","key":"10.1016\/j.bbr.2019.111967_bib0445","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1017\/S1461145708009309","article-title":"A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression","volume":"11","author":"Brunoni","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"12","key":"10.1016\/j.bbr.2019.111967_bib0450","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.mp.4002075","article-title":"Is it time to reassess the BDNF hypothesis of depression?","volume":"12","author":"Groves","year":"2007","journal-title":"Mol. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbr.2019.111967_bib0455","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.biopsych.2009.05.017","article-title":"A brain-derived neurotrophic factor haplotype is associated with therapeutic response in obsessive-compulsive disorder","volume":"66","author":"Real","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbr.2019.111967_bib0460","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.biopsych.2008.05.005","article-title":"Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications","volume":"64","author":"Sen","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbr.2019.111967_bib0465","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.pnpbp.2011.06.013","article-title":"Serum BDNF levels before treatment predict SSRI response in depression","volume":"35","author":"Wolkowitz","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbr.2019.111967_bib0470","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.psychres.2014.11.058","article-title":"Efficacy of cognitive-behavioral therapy for obsessive\u2013compulsive disorder","volume":"225","author":"McKay","year":"2015","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.bbr.2019.111967_bib0475","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1440-1819.2006.01587.x","article-title":"Effect of cognitive training focusing on organizational strategies in patients with obsessive\u2010compulsive disorder","volume":"60","author":"Park","year":"2006","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"7705","key":"10.1016\/j.bbr.2019.111967_bib0480","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-018-0087-1","article-title":"New approaches for brain repair\u2014from rescue to reprogramming","volume":"557","author":"Barker","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbr.2019.111967_bib0485","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1440-1819.2006.01519.x","article-title":"Successful treatment for obsessive\u2010compulsive disorder with addition of low\u2010dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain\u2010derived neurotrophic factor levels","volume":"60","author":"Yoshimura","year":"2006","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.bbr.2019.111967_bib0490","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.eurpsy.2011.09.005","article-title":"Variation in the BDNF Val66Met polymorphism and response to cognitive-behavior therapy in obsessive-compulsive disorder","volume":"27","author":"Fullana","year":"2012","journal-title":"Eur. Psychiatry"},{"issue":"8","key":"10.1016\/j.bbr.2019.111967_bib0495","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.euroneuro.2006.04.010","article-title":"Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients","volume":"16","author":"Bocchio-Chiavetto","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2019.111967_bib0500","first-page":"611","article-title":"No association between BDNF Val66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population","volume":"12","author":"Umehara","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.bbr.2019.111967_bib0505","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2004.03.002","article-title":"The impact of age, weight and gender on BDNF levels in human platelets and plasma","volume":"26","author":"Lommatzsch","year":"2005","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.bbr.2019.111967_bib0510","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainresbull.2009.06.022","article-title":"The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels","volume":"81","author":"Ozan","year":"2010","journal-title":"Brain Res. Bull."},{"issue":"1\u20133","key":"10.1016\/j.bbr.2019.111967_bib0515","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainresbull.2007.03.009","article-title":"Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data","volume":"73","author":"Trajkovska","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbr.2019.111967_bib0520","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ajp.2017.10.014","article-title":"BDNF gene and obsessive compulsive disorder risk,symptom dimensions and treatment response","volume":"38","author":"MJ","year":"2018","journal-title":"Asian J. Psychiatr."},{"issue":"3","key":"10.1016\/j.bbr.2019.111967_bib0525","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2174\/1570159X13666150403231920","article-title":"Nerve growth factor: a focus on neuroscience and therapy","volume":"13","author":"Aloe","year":"2015","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2019.111967_bib0530","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1146\/annurev.neuro.24.1.1217","article-title":"Nerve growth factor signaling, neuroprotection, and neural repair","volume":"24","author":"Sofroniew","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"issue":"35","key":"10.1016\/j.bbr.2019.111967_bib0535","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.1523\/JNEUROSCI.2594-09.2009","article-title":"NGF is essential for hippocampal plasticity and learning","volume":"29","author":"Conner","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2019.111967_bib0540","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fncel.2014.00220","article-title":"Nerve growth factor is primarily produced by GABAergic neurons of the adult rat cortex","volume":"8","author":"Biane","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.bbr.2019.111967_bib0545","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jagp.2013.01.014","article-title":"Reduced serum nerve growth factor in patients with late-life depression","volume":"21","author":"Diniz","year":"2013","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbr.2019.111967_bib0550","first-page":"88","article-title":"Stress, anxiety and schizophrenia and neurotrophic factors: the pioneer studies with nerve growth factor","volume":"44","author":"Gioiosa","year":"2009","journal-title":"Riv. Psichiatr."},{"key":"10.1016\/j.bbr.2019.111967_bib0555","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijdevneu.2015.12.005","article-title":"The impact of two mild stressors on the nerve growth factor (NGF) immunoreactivity in the amygdala in aged rats compared to adult ones","volume":"49","author":"Badowska-Szalewska","year":"2016","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.bbr.2019.111967_bib0560","first-page":"925","article-title":"Significantly lower nerve growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-analysis and systematic review","volume":"11","author":"Chen","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bbr.2019.111967_bib0565","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jad.2015.05.067","article-title":"Serum levels of nerve growth factor (NGF) in patients with major depression disorder and suicide risk","volume":"184","author":"Wiener","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbr.2019.111967_bib0570","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/PRBM.S104814","article-title":"Mental disorders, functional impairment, and nerve growth factor","volume":"10","author":"Salles","year":"2017","journal-title":"Psychol. Res. Behav. Manag."},{"key":"10.1016\/j.bbr.2019.111967_bib0575","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jad.2015.07.035","article-title":"Association between genetic variants related to glutamatergic, dopaminergic and neurodevelopment pathways and white matter microstructure in child and adolescent patients with obsessive\u2013compulsive disorder","volume":"186","author":"Gass\u00f3","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.bbr.2019.111967_bib0580","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1101\/lm.76006","article-title":"NT-3 facilitates hippocampal plasticity and learning and memory by regulating neurogenesis","volume":"13","author":"Shimazu","year":"2006","journal-title":"Learn. Mem."},{"issue":"6","key":"10.1016\/j.bbr.2019.111967_bib0585","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1083\/jcb.200603061","article-title":"Neurotrophin 3 induces structural and functional modification of synapses through distinct molecular mechanisms","volume":"175","author":"Je","year":"2006","journal-title":"J. Cell Biol."},{"issue":"11","key":"10.1016\/j.bbr.2019.111967_bib0590","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1080\/00207450802174589","article-title":"Does neurotropin-3 have a therapeutic implication in major depression?","volume":"118","author":"Pae","year":"2008","journal-title":"Int. J. Neurosci."},{"issue":"12","key":"10.1016\/j.bbr.2019.111967_bib0595","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1096\/fj.05-3845fje","article-title":"Haploin-sufficiency for trkB and trkC receptors induces cell loss and accumulation of \u03b1-synuclein in the substantia nigra","volume":"19","author":"von Bohlen","year":"2005","journal-title":"Faseb. J."},{"issue":"12","key":"10.1016\/j.bbr.2019.111967_bib0600","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s00702-006-0498-2","article-title":"Neurotrophin receptor heterozygosity causes deficits in catecholaminergic innervation of amygdala and hippocampus in aged mice","volume":"113","author":"und Halbach","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbr.2019.111967_bib0605","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2010.12.027","article-title":"Direct and indirect effects of neuropeptide Y and neurotrophin 3 on myelination in the neonatal brains","volume":"1373","author":"Hashimoto","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2019.111967_bib0610","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-clinpsy-032210-104507","article-title":"Diffusion imaging, white matter, and psychopathology","volume":"7","author":"Thomason","year":"2011","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.bbr.2019.111967_bib0615","doi-asserted-by":"crossref","DOI":"10.1177\/0963689717753188","article-title":"A combination of NT-4\/5 and GDNF is favorable for cultured human nigral neural progenitor cells","author":"Di Santo","year":"2018","journal-title":"Cell Transplant."},{"issue":"3","key":"10.1016\/j.bbr.2019.111967_bib0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052461","article-title":"Increased expression of neurotrophin 4 following focal cerebral ischemia in adult rat brain with treadmill exercise","volume":"8","author":"Chung","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bbr.2019.111967_bib0625","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jpsychires.2009.11.020","article-title":"Increased neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes","volume":"44","author":"Fernandes","year":"2010","journal-title":"J. Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.bbr.2019.111967_bib0630","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpsychires.2010.05.015","article-title":"Peripheral biomarkers and illness activity in bipolar disorder","volume":"45","author":"Kapczinski","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbr.2019.111967_bib0635","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pnpbp.2014.09.014","article-title":"Elevated neurotrophin-3 and neurotrophin 4\/5 levels in unmedicated bipolar depression and the effects of lithium","volume":"56","author":"Loch","year":"2015","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2019.111967_bib0640","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jpsychires.2016.05.009","article-title":"State-dependent increase in the levels of neurotrophin-3 and neurotrophin-4\/5 in patients with bipolar disorder: a meta-analysis","volume":"79","author":"Tseng","year":"2016","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.bbr.2019.111967_bib0645","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neulet.2007.01.002","article-title":"Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder","volume":"415","author":"Walz","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.bbr.2019.111967_bib0650","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1590\/1516-4446-2014-1380","article-title":"Decreased plasma neurotrophin-4\/5 levels in bipolar disorder patients in mania","volume":"36","author":"Barbosa","year":"2014","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.bbr.2019.111967_bib0655","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.psyneuen.2014.05.011","article-title":"Elevated levels of plasma brain derived neurotrophic factor in rapid cycling bipolar disorder patients","volume":"47","author":"Munkholm","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"14","key":"10.1016\/j.bbr.2019.111967_bib0660","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jpsychires.2008.01.010","article-title":"Altered expression of neurotrophic factors in patients with major depression","volume":"42","author":"Otsuki","year":"2008","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.bbr.2019.111967_bib0665","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.1038\/tp.2016.20","article-title":"A common NTRK2 variant is associated with emotional arousal and brain white-matter integrity in healthy young subjects","volume":"6","author":"Spalek","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbr.2019.111967_bib0670","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neuroimage.2013.05.095","article-title":"Relation between variants in the neurotrophin receptor gene, NTRK3, and white matter integrity in healthy young adults","volume":"82","author":"Braskie","year":"2013","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.bbr.2019.111967_bib0675","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1530\/eje.0.1330390","article-title":"Thyroid hormones and brain development","volume":"133","author":"Bernal","year":"1995","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.bbr.2019.111967_bib0680","first-page":"94","article-title":"The role of thyroid hormones in prenatal and neonatal neurological development\u2014current perspectives","volume":"14","author":"Porterfield","year":"1993","journal-title":"Endocr. Rev."},{"issue":"19","key":"10.1016\/j.bbr.2019.111967_bib0685","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1001\/archinte.166.19.2109","article-title":"Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions","volume":"166","author":"Sareen","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"10.1016\/j.bbr.2019.111967_bib0690","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/sj.mp.4000963","article-title":"Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain","volume":"7","author":"Bauer","year":"2002","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbr.2019.111967_bib0695","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00213-017-4799-y","article-title":"Effects of hypothyroidism on serotonin 1A receptors in the rat brain","volume":"235","author":"Lee","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2019.111967_bib0700","article-title":"Thyroid function in obsessive-compulsive disorder","author":"Joffe","year":"1988","journal-title":"Psychiatr. J. Univ. Ott."},{"issue":"1","key":"10.1016\/j.bbr.2019.111967_bib0705","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0165-1781(91)90049-U","article-title":"TRH stimulation test in obsessive-compulsive patients","volume":"38","author":"Aizenberg","year":"1991","journal-title":"Psychiatry Res."},{"issue":"12","key":"10.1016\/j.bbr.2019.111967_bib0710","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00127-014-0895-z","article-title":"Physical diseases among persons with obsessive compulsive symptoms and disorder: a general population study","volume":"49","author":"Witthauer","year":"2014","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"5","key":"10.1016\/j.bbr.2019.111967_bib0715","first-page":"493","article-title":"Obsessive-compulsive disorder and the study of thyroid function","volume":"17","author":"Hantouche","year":"1991","journal-title":"LEncephale"},{"issue":"4","key":"10.1016\/j.bbr.2019.111967_bib0720","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000026545","article-title":"Prevalence of psychiatric disorders in thyroid diseased patients","volume":"38","author":"Placidi","year":"1998","journal-title":"Neuropsychobiology"},{"issue":"2","key":"10.1016\/j.bbr.2019.111967_bib0725","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/1044546041649048","article-title":"Coexistent hypothyroidism, psychosis, and severe obsessions in an adolescent: a 10-year follow-up","volume":"14","author":"Bhatara","year":"2004","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2019.111967_bib0730","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/cap.2005.15.581","article-title":"Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: effects of clomipramine treatment","volume":"15","author":"McCracken","year":"2005","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"3 suppl","key":"10.1016\/j.bbr.2019.111967_bib0735","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/1359786806064310","article-title":"Augmentation and combination strategies for depression","volume":"20","author":"DeBattista","year":"2006","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2019.111967_bib0740","doi-asserted-by":"crossref","first-page":"187","DOI":"10.31887\/DCNS.2010.12.2\/mkellner","article-title":"Drug treatment of obsessive-compulsive disorder","volume":"12","author":"Kellner","year":"2010","journal-title":"Dialogues Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.bbr.2019.111967_bib0745","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00004714-199108000-00004","article-title":"A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder","volume":"11","author":"Pigott","year":"1991","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2019.111967_bib0750","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1600-0447.2004.00502.x","article-title":"Obsessive\u2013compulsive disorder: a critical review of therapeutic perspectives","volume":"111","author":"Schruers","year":"2005","journal-title":"Acta Psychiatr. Scand."},{"issue":"11","key":"10.1016\/j.bbr.2019.111967_bib0755","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2174\/1389450111314110009","article-title":"Regulation of neurotrophic factors and energy metabolism by antidepressants in astrocytes","volume":"14","author":"Martin","year":"2013","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/j.bbr.2019.111967_bib0760","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neurobiolaging.2005.08.018","article-title":"Neurotrophic factors and regulation of mood: role of exercise, diet and metabolism","volume":"26","author":"Duman","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbr.2019.111967_bib0765","first-page":"59","article-title":"Neural stem cell regulation, fibroblast growth factors, and the developmental origins of neuropsychiatric disorders","volume":"4","author":"Stevens","year":"2010","journal-title":"Front. Neurosci."},{"issue":"7","key":"10.1016\/j.bbr.2019.111967_bib0770","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40263-013-0076-8","article-title":"Intranasal insulin as a treatment for Alzheimer\u2019s disease: a review of basic research and clinical evidence","volume":"27","author":"Freiherr","year":"2013","journal-title":"CNS Drugs"},{"issue":"21","key":"10.1016\/j.bbr.2019.111967_bib0775","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.4103\/1673-5374.145342","article-title":"New drug treatments show neuroprotective effects in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"9","author":"H\u00f6lscher","year":"2014","journal-title":"Neural Regen. Res."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432819303080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432819303080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:13:47Z","timestamp":1759065227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432819303080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":155,"alternative-id":["S0166432819303080"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2019.111967","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obsessive-compulsive disorder and growth factors: A comparative review","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2019.111967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111967"}}